Premium
Treatment planning in cutaneous T‐Cell lymphoma
Author(s) -
Vonderheid Eric C.
Publication year - 2003
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1396-0296.2003.01638.x
Subject(s) - medicine , dermatology , lymphoma , cutaneous t cell lymphoma , medline , mycosis fungoides , political science , law
Effective long‐term management of cutaneous T‐cell lymphoma (CTCL) requires administration of skin‐directed therapies such as topically applied nitrogen mustard or photochemotherapy to achieve a complete response in clinically early disease (patch and thin‐plaque‐phase mycosis fungoides, MF) and often the concomitant administration of well‐tolerated drugs with systemic effects such as interferon alfa, bexarotene, methotrexate or extracorporeal photopheresis in more advanced, but not highly aggressive/nontransformed disease (thick plaque or tumor phase MF or erythrodermic CTCL). The author's approach is provided as a guide for dermatologists in private practice.